1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Theravance Biopharma Inc (TBPH) CEO Rick E Winningham Bought $245,000 of Shares

August 11, 2017 | About:

CEO of Theravance Biopharma Inc (NASDAQ:TBPH) Rick E Winningham bought 10,000 shares of TBPH on 08/11/2017 at an average price of $24.5 a share. The total cost of this purchase was $245,000.

Theravance Biopharma Inc is a diversified biopharmaceutical company. It is engaged in discovery, research, development and commercialization of human therapeutics. Theravance Biopharma Inc has a market cap of $1.3 billion; its shares were traded at around $24.10 with and P/S ratio of 36.97.

CEO Recent Trades:

  • CEO Rick E Winningham bought 10,000 shares of TBPH stock on 08/11/2017 at the average price of $24.5. The price of the stock has decreased by 1.63% since.

Directors and Officers Recent Trades:

  • Director Henrietta Fore bought 6,000 shares of TBPH stock on 08/11/2017 at the average price of $23.99. The price of the stock has increased by 0.46% since.

For the complete insider trading history of TBPH, click here

.

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


GuruFocus has detected 3 Warning Signs with Theravance Biopharma Inc $TBPH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

Performances of the stocks mentioned by insider


User Generated Screeners


liuzishuNon-div M-score
blomgGreenblatt
pbarker46Momentum
merknt84div5
merknt84div4
merknt84div3
merknt84div2
DANGORDON**** LOW PE AND PEG
DANGORDON***** BEST STOCKS 50 ABOVE
DANGORDON***** BEST STOCKS
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK